MBIO mustangbio.com: Company Current Liabilities

Brandmark of Mustang Bio (MBIO)

Mustang Bio, Inc. (MBIO) relies on unique treatments for leukemia and rare genetic pathologies. The history of short-term credits and loans confirms the financial dynamics, where 0.00 expresses the metric value today. The robotization of vector assembly minimizes product defects, while expansion into the CAR-T drug segment through partnerships with pharma behemoths provides access to untapped market niches.

MBIO mustangbio.com Short-Term Debt Volume (07/04/2022 - 10/31/2026)

Summary analytical data breakdowns for Mustang Bio Inc (MBIO)

- current quotes and average value forecast:
Price Chart Mustang Bio Corp|MBIO - Consensus Target
- company stock capitalization data:
Market Valuation Mustang Bio, Inc.|MBIO - Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Mustang Bio|MBIO - Book Valuation of Business|Market Cap to Net Assets Ratio mustangbio.com|MBIO - Aggregate Business Assets
- debt level and financial liquidity data:
Total Debt to Capital Mustang Bio, Inc.|MBIO - Long-Term Debt to Capital|Short-Term Debt to Equity Mustang Bio Corp|MBIO - Company Aggregate Debt|Debts to Book Capitalization Mustang Bio, Inc.|MBIO - Long-Term Indebtedness|Company Current Liabilities Mustang Bio|Quick Ratio mustangbio.com
- earnings and multiples data:
MBIO - Company Net Income
Fundamental valuation:mustangbio.com (MBIO)
Manufactured products of Mustang Bio Corp

The assessment of Mustang Bio, Inc. (MBIO) solvency is based on an analysis of liabilities maturing within one year, which determine the risk of liquidity loss and dependence on external refinancing. The dynamics of short-term borrowed resources demonstrate the company's ability to service its loans, which is critical for maintaining costly developments in gene therapy and CAR-T platforms with long-term patent protection cycles.

Analysis of competing companies

TEM - Company Short-Term Debt|Qiagen NV (QGEN) - Company Current Liabilities|IONS (Ionis Pharma) - Company Current Liabilities|Repligen Inc. (RGEN) - Company Short-Term Debts|Company Short-Term Debt Avidity Biosciences|crisprtx.com (CRSP) - Short-Term Debt Volume|Company Current Liabilities WGS (GeneDx)|Amount of Current Liabilities RARE|Company Short-Term Debts BEAM (Beam Therapeutics Corp)|Company Short-Term Debts Sarepta Corp SRPT|TWST - Company Short-Term Debt|TXG (10xgenomics.com) - Company Short-Term Indebtedness|NTLA: Company Short-Term Debts|Short-Term Indebtedness Stoke Therapeutics Inc STOK|Company Current Liabilities BLFS|WVE: Company Short-Term Loans and Borrowings|Company Short-Term Debts MAZE|Company Short-Term Debt SION (sionnatx.com)|Company Short-Term Debts PRME (Prime Medicine)|Short-Term Debt Volume Taysha Gene Therapies Inc (TSHA)|QURE - Company Short-Term Debt|Short-Term Debt MeiraGTx Corp|RGNX (REGENXBIO Inc.) - Company Current Liabilities|solidbio.com - Company Short-Term Loans and Borrowings|OCGN (Ocugen) - Company Short-Term Debts|Pacific Biosciences of California, Inc. (PACB) - Short-Term Debt Volume|Company Short-Term Debt Benitec (BNTC)|Design Corp - Company Short-Term Indebtedness|Company Short-Term Debts RCKT (Rocket Pharmaceuticals)|FDMT - Company Current Liabilities|LXEO: Company Current Liabilities|Short-Term Debt Volume Korro Bio, Inc. KRRO|Editas (EDIT) - Company Short-Term Debt|Company Current Liabilities Silence Therapeutics Corp|PRQR (ProQR) - Company Short-Term Debts|Company Short-Term Debt CDXS|Company Short-Term Debts SGMO|Short-Term Debt Volume nautilus.bio|Company Short-Term Debt Metagenomi, Inc MGX|precisionbiosciences.com (DTIL) - Short-Term Debt|Generation Bio Corp - Company Short-Term Debts|BOLD (boundlessbio.com) - Company Short-Term Indebtedness|exicuretx.com (XCUR) - Company Short-Term Debt|Company Short-Term Indebtedness IMNN|PHIO (Phio Pharmaceuticals Corp) - Company Short-Term Debts|Company Short-Term Debts TransCode|Company Short-Term Debt Bionano Genomics, Inc. (BNGO)|Company Current Liabilities adnas.com APDN|bluebird bio - Company Current Liabilities|Company Short-Term Debts ImmunoPrecise Antibodies Ltd IPA|OMGA - Company Short-Term Debt|Short-Term Debt Volume Singular Genomics Corp OMIC|RGLS (Regulus Therapeutics) - Company Current Liabilities|SYRS: Amount of Current Liabilities|TBIO (Telesis Bio) - Company Short-Term Debts|Company Short-Term Debts TRACON Pharmaceuticals Inc.|Company Short-Term Debt Unity Bio (UBX)